Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederendpts.com
ENDPOINTS NEWS
Get the latest updates from ENDPOINTS NEWS directly as they happen.
Follow now 168 followers
Latest posts
Last updated about 5 hours ago
Federal judge orders block on parts of HHS reorganization plan after states sue
about 5 hours ago
A Rhode Island judge on Tuesday issued a preliminary injunction against parts...
PBM reforms fail to make Senate version of Trump's megabill
about 5 hours ago
Efforts to rein in pharmacy benefit managers, for which drugmakers have been...
AN Venture Partners lines up $200M freshman fund to champion Japanese innovation
about 5 hours ago
At a time when few biotech venture capital firms are coming out...
The biggest health tech stories of 2025 — so far
about 10 hours ago
We’re officially halfway through 2025. Rather than wait for the end of...
Broad Institute conducts layoffs as it preps for cuts in federal funding; Dyne’s financing
about 10 hours ago
Plus, news about Bayer, Tempus AI, Apellis, Sobi, Nektar Therapeutics, Cybin, atai...
Advocates urge J&J to ‘put everything on the table’ for gene therapy despite failed trial
about 11 hours ago
For Lewis Winton, the world looks different from one eye In the...
Kevin Tang's Concentra snags another buyout, this time for IGM Biosciences
about 11 hours ago
Kevin Tang is on a hot streak Concentra Biosciences, the shell company...
Sama Fertility raises $3.8M to make IVF more accessible
about 12 hours ago
Sama Fertility has raised $3.8 million to help people undergo IVF, mostly...
Unnatural Products taps argenx's help for ringed molecules, expands internal work into obesity
about 13 hours ago
Unnatural Products has signed on argenx as its latest partner to take...
Beckley touts positive mid-stage psychedelic data, advancing atai merger
about 15 hours ago
Beckley Psytech said its intranasal treatment bested a small-dose comparator in a...
Exclusive: Bob Langer-founded Syntis Bio gets $33M Series A for obesity, rare disease drugs
about 15 hours ago
A Boston biotech working on a different approach to oral obesity drugs...
Protagonist unveils 'triple-G' obesity pill, but human trials are nearly a year away
1 day ago
Protagonist Therapeutics is a late entrant into the obesity space, but it...